Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Asal AB
AB
Active
Org 5595228452
Strindbergsgatan 10, 754 21
Uppsala
Retail sale of pharmaceutical products
·
NACE 4773
Est. 2025 · 1 year old
1 employees
Monitor
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
Asal AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
1M
1M
1M
0M
0M
2026: 1M
1M
2026
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2026: 0M
0M
2026
Income statement
SEK thousands
Item
2026
Revenue
784
Staff expenses
−191
EBITDA
470
Depreciation & amort.
—
EBIT
470
Net financials
0
Profit before tax
470
Tax
−97
Net profit
373
Balance sheet
SEK thousands
Item
2026
Total assets
693
Equity
398
Long-term debt
—
Short-term debt
295
Total debt
295
Financial ratios
5-year trend
EBITDA margin
59,9 %
This company
15,8 %
Market median
This company
Market median
279% above market
2026
2026
Equity ratio
57,4 %
This company
38,2 %
Market median
This company
Market median
50% above market
2026
2026
Return on equity
93,7 %
This company
18,4 %
Market median
This company
Market median
409% above market
2026
2026
Net profit margin
47,6 %
This company
8,1 %
Market median
This company
Market median
488% above market
2026
2026
Asset turnover
1,13×
This company
1,12×
Market median
This company
Market median
1% above market
2026
2026
Debt / equity
0,74×
This company
0,62×
Market median
This company
Market median
19% above market
2026
2026
Annual reports & filings
Annual report 2026
Filed via Bolagsverket / SCB · Period 2025-03-10 – 2026-02-28
View
PDF
More on Asal AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
